John Vidyadhar Hegde

Title(s)HS Assistant Clinical Professor, Radiation Oncology
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Results of an AI-Based Image Review System to Detect Patient Misalignment Errors in a Multi-Institutional Database of CBCT-Guided Radiotherapy Treatments. Int J Radiat Oncol Biol Phys. 2024 Mar 12. Luximon DC, Neylon J, Ritter T, Agazaryan N, Hegde JV, Steinberg ML, Low DA, Lamb JM. PMID: 38485098.
      View in: PubMed   Mentions:    Fields:    
    2. Seizure outcomes following single-fraction versus hypofractionated radiosurgery for brain metastases: a single-center experience. J Neurosurg. 2023 10 01; 139(4):925-933. Miller MS, Kim W, Harary M, Savjani RR, Lee J, Telesca D, Tenn S, Hegde J, Kaprealian T. PMID: 37856892.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Retrospective examination of pseudoprogression in IDH mutant gliomas. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad028. Wetzel EA, Farrell MJ, Eldred BSC, Liu V, Saha I, Zapanta Rinonos S, Prins T, Li T, Cao M, Hegde J, Kaprealian T, Khanlou N, Liau LM, Nghiemphu PL, Cloughesy TF, Chong RA, Ellingson BM, Lai A. PMID: 37128507; PMCID: PMC10148681.
      View in: PubMed   Mentions:
    4. Experience of Telemedicine Visits in Radiation Oncology During the COVID-19 Pandemic: A US National Survey and Lessons Learned for Incorporating Telemedicine Post-COVID-19. Adv Radiat Oncol. 2022 Dec 12; 100924. Ma TM, Parikh NR, Philipson RG, van Dams R, Chang EM, Hegde JV, Kishan AU, Kaprealian TB, Steinberg ML, Raldow AC. PMID: 36532603; PMCID: PMC9744187.
      View in: PubMed   Mentions: 3  
    5. Radiation Therapy for Mantle Cell Lymphoma with Orbital Involvement. Radiol Imaging Cancer. 2022 07; 4(4):e220027. Savjani RR, Ati S, Sadeghi S, Bonelli L, Kaprealian TB, Hegde JV. PMID: 35866891; PMCID: PMC9358483.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison. Adv Radiat Oncol. 2022 Jul-Aug; 7(4):100944. Wu TC, Xiang M, Nickols NG, Tenn S, Agazaryan N, Hegde JV, Steinberg ML, Cao M, Kishan AU. PMID: 35521072; PMCID: PMC9061255.
      View in: PubMed   Mentions:
    7. A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes. Cancers (Basel). 2022 Feb 14; 14(4). Woods KE, Ma TM, Cook KA, Morris ED, Gao Y, Sheng K, Kishan AU, Hegde JV, Felix C, Basehart V, Narahara K, Shen Z, Tenn S, Steinberg ML, Chin RK, Cao M. PMID: 35205686; PMCID: PMC8870161.
      View in: PubMed   Mentions: 2  
    8. Simultaneous radiosurgery for multiple brain metastases: technical overview of the UCLA experience. Radiat Oncol. 2021 Nov 17; 16(1):221. Agazaryan N, Tenn S, Lee C, Steinberg M, Hegde J, Chin R, Pouratian N, Yang I, Kim W, Kaprealian T. PMID: 34789300; PMCID: PMC8597274.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    9. High-Dose Rate Interstitial Spine Brachytherapy Using an Intraoperative Mobile Computed Tomography-Guided Surgical Navigation System. Oper Neurosurg (Hagerstown). 2021 11 15; 21(6):507-515. Medina R, Macyszyn L, Lim AS, Attiah M, Kafka-Peterson K, Kaprelian T, Hegde JV, Venkat P, Lee A, Park SJ, Chang AJ. PMID: 34670276.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Ventilation measurements using fast-helical free-breathing computed tomography. Med Phys. 2021 Oct; 48(10):6094-6105. Low DA, O'Connell D, Lauria M, Stiehl B, Naumann L, Lee P, Hegde J, Barjaktarevic I, Goldin J, Santhanam A. PMID: 34410014; PMCID: PMC8568635.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Automated Non-Coplanar VMAT for Dose Escalation in Recurrent Head and Neck Cancer Patients. Cancers (Basel). 2021 Apr 15; 13(8). Woods K, Chin RK, Cook KA, Sheng K, Kishan AU, Hegde JV, Tenn S, Steinberg ML, Cao M. PMID: 33921062; PMCID: PMC8071369.
      View in: PubMed   Mentions: 5  
    12. A Framework for Sharing Radiation Dose Distribution Maps in the Electronic Medical Record for Improving Multidisciplinary Patient Management. Radiol Imaging Cancer. 2021 03; 3(2):e200075. Savjani RR, Salamon N, Deng J, Ma M, Tenn S, Agazaryan N, Hegde J, Kaprealian T. PMID: 33817649; PMCID: PMC8011443.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. A Practical Guide for Navigating the Design, Build, and Clinical Integration of Electronic Patient-Reported Outcomes in the Radiation Oncology Department. Pract Radiat Oncol. 2021 Jul-Aug; 11(4):e376-e383. Philipson RG, Wu AD, Curtis WC, Jablonsky DJ, Hegde JV, McCloskey SA, Kaprealian TB, Steinberg ML, Kishan AU, Raldow AC. PMID: 33460827.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Missing the Near Miss: Recognizing Valuable Learning Opportunities in Radiation Oncology. Pract Radiat Oncol. 2021 May-Jun; 11(3):e256-e262. Kundu P, Jung OS, Valle LF, Edmondson AC, Agazaryan N, Hegde J, Steinberg M, Raldow A. PMID: 32971273.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Resilience vs. Vulnerability: Psychological Safety and Reporting of Near Misses with Varying Proximity to Harm in Radiation Oncology. Jt Comm J Qual Patient Saf. 2020 Sep 20. Jung OS, Kundu P, Edmondson AC, Hegde J, Agazaryan N, Steinberg M, Raldow A. PMID: 33092989.
      View in: PubMed   Mentions: 1     Fields:    
    16. Time-Driven Activity-Based Costing Comparison of Stereotactic Radiosurgery to Multiple Brain Lesions Using Single-Isocenter Versus Multiple-Isocenter Technique. Int J Radiat Oncol Biol Phys. 2020 11 15; 108(4):999-1007. Parikh NR, Kundu P, Levin-Epstein R, Chang EM, Agazaryan N, Hegde JV, Steinberg ML, Tenn SE, Kaprealian TB. PMID: 32603774.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    17. The Timeliness Initiative: Continuous Process Improvement for Prompt Initiation of Radiation Therapy Treatment. Adv Radiat Oncol. 2020 Sep-Oct; 5(5):1014-1021. Agazaryan N, Chow P, Lamb J, Cao M, Raldow A, Beron P, Hegde J, Steinberg M. PMID: 33083664; PMCID: PMC7557132.
      View in: PubMed   Mentions: 8  
    18. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. Eur Urol. 2020 01; 77(1):3-10. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. PMID: 30992160; PMCID: PMC7521828.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    19. Patient perspectives and treatment regret after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal cancer: Findings from a phase II trial. Head Neck. 2019 08; 41(8):2768-2776. Shaverdian N, Hegde JV, Felix C, Hsu S, Basehart V, Steinberg ML, Chen AM. PMID: 30958605.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    20. Respiratory motion-resolved, self-gated 4D-MRI using Rotating Cartesian K-space (ROCK): Initial clinical experience on an MRI-guided radiotherapy system. Radiother Oncol. 2018 06; 127(3):467-473. Han F, Zhou Z, Du D, Gao Y, Rashid S, Cao M, Shaverdian N, Hegde JV, Steinberg M, Lee P, Raldow A, Low DA, Sheng K, Yang Y, Hu P. PMID: 29753549.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    21. Accelerated 3D bSSFP imaging for treatment planning on an MRI-guided radiotherapy system. Med Phys. 2018 Jun; 45(6):2595-2602. Gao Y, Zhou Z, Han F, Cao M, Shaverdian N, Hegde JV, Bista BB, Steinberg M, Lee P, Raldow A, Low DA, Yang Y, Hu P. PMID: 29663419.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy. Am J Clin Oncol. 2018 05; 41(5):502-507. Hegde JV, Collins SP, Fuller DB, King CR, Demanes DJ, Wang PC, Kupelian PA, Steinberg ML, Kamrava M. PMID: 27322703.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    23. Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer. J Nucl Med. 2018 11; 59(11):1714-1721. Calais J, Kishan AU, Cao M, Fendler WP, Eiber M, Herrmann K, Ceci F, Reiter RE, Rettig MB, Hegde JV, Shaverdian N, King CR, Steinberg ML, Czernin J, Nickols NG. PMID: 29653978; PMCID: PMC6225538.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    24. Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer. Cureus. 2018 Apr 06; 10(4):e2442. Hegde JV, Cao M, Yu VY, Kishan AU, Shaverdian N, Lamb J, Steinberg ML. PMID: 29881655; PMCID: PMC5990029.
      View in: PubMed   Mentions: 4  
    25. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):883-888. Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. PMID: 29976500.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Head and neck cancer reirradiation with interstitial high-dose-rate brachytherapy. Head Neck. 2018 07; 40(7):1524-1533. Hegde JV, Demanes DJ, Veruttipong D, Chin RK, Park SJ, Kamrava M. PMID: 29573121.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    27. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. JAMA. 2018 03 06; 319(9):896-905. Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. PMID: 29509865; PMCID: PMC5885899.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    28. The patient's perspective on breast radiotherapy: Initial fears and expectations versus reality. Cancer. 2018 04 15; 124(8):1673-1681. Shaverdian N, Wang X, Hegde JV, Aledia C, Weidhaas JB, Steinberg ML, McCloskey SA. PMID: 29479673.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    29. 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning. J Nucl Med. 2018 02; 59(2):230-237. Calais J, Czernin J, Cao M, Kishan AU, Hegde JV, Shaverdian N, Sandler K, Chu FI, King CR, Steinberg ML, Rauscher I, Schmidt-Hegemann NS, Poeppel T, Hetkamp P, Ceci F, Herrmann K, Fendler WP, Eiber M, Nickols NG. PMID: 29123013; PMCID: PMC5807533.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    30. Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2018 03 01; 100(3):647-651. Hegde JV, Shaverdian N, Felix C, Wang PC, Veruttipong D, Hsu S, Riess JW, Rao SD, Daly ME, Chen AM. PMID: 29246721.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    31. Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial. Cancer. 2018 02 01; 124(3):521-529. Hegde JV, Shaverdian N, Daly ME, Felix C, Wong DL, Rosove MH, Garst JH, Wang PC, Veruttipong D, Rao S, Fragoso RC, Riess JW, Steinberg ML, Chen AM. PMID: 29044458; PMCID: PMC5916816.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    32. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer. Clin Breast Cancer. 2018 04; 18(2):e205-e218. Hegde JV, Wang X, Attai DJ, DiNome ML, Kusske A, Hoyt AC, Hurvitz SA, Weidhaas JB, Steinberg ML, McCloskey SA. PMID: 29050918.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy. Brachytherapy. 2017 Nov - Dec; 16(6):1106-1112. Hegde JV, Demanes DJ, Veruttipong D, Raince J, Park SJ, Raman SS, Nickols NG, King CR, Kishan AU, Steinberg ML, Kamrava M. PMID: 28807747.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    34. Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer. Breast Cancer Res Treat. 2017 Nov; 166(1):145-156. Hegde JV, Wang X, Attai DJ, DiNome ML, Kusske A, Hoyt AC, Hurvitz SA, Weidhaas JB, Steinberg ML, McCloskey SA. PMID: 28702891.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    35. Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy. Graefes Arch Clin Exp Ophthalmol. 2017 Sep; 255(9):1843-1850. Hegde JV, McCannel TA, McCannel CA, Lamb J, Wang PC, Veruttipong D, Almanzor R, Demanes DJ, Kamrava M. PMID: 28597076.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer. Urology. 2017 Sep; 107:171-177. Hegde JV, Veruttipong D, Said JW, Reiter RE, Steinberg ML, King CR, Kishan AU. PMID: 28552819; PMCID: PMC6986738.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Advances in Radiation Oncology: What to Consider. Otolaryngol Clin North Am. 2017 Aug; 50(4):755-764. Hegde JV, Chen AM, Chin RK. PMID: 28527523.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Imaging and Pathology Correlations for Different Risk Stratification Models for Intermediate-risk Prostate Cancer. Anticancer Res. 2017 03; 37(3):1237-1242. Ellis-Caleo T, Hegde JV, Batth S, Mesko S, Reiter R, Margolis D, Kamrava M. PMID: 28314287.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    39. Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy. Prostate Cancer Prostatic Dis. 2017 06; 20(2):241-248. Hegde JV, Margolis DJ, Wang PC, Reiter RE, Huang J, Steinberg ML, Kamrava M. PMID: 28139757; PMCID: PMC6946385.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy. Br J Radiol. 2016; 89(1059):20150963. Shaverdian N, Tenn S, Veruttipong D, Wang J, Hegde J, Lee C, Cao M, Agazaryan N, Steinberg M, Kupelian P, Lee P. PMID: 26764282; PMCID: PMC4986505.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    41. Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists? BJU Int. 2016 Apr; 117(4):584-91. Kamrava M, Hegde JV, Abgaryan N, Chang E, Le JD, Wang J, Kupelian PA, Marks LS. PMID: 25684394.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. How we used a patient visit tracker tool to advance experiential learning in systems-based practice and quality improvement in a medical student clinic. Med Teach. 2016; 38(1):36-40. Chen CA, Park RJ, Hegde JV, Jun T, Christman MP, Yoo SM, Yamasaki A, Berhanu A, Vohra-Khullar P, Remus K, Schwartzstein RM, Weinstein AR. PMID: 25401409.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy. Clin Genitourin Cancer. 2014 Oct; 12(5):e173-9. Rose BS, Chen MH, Zhang D, Hirsch MS, Richie JP, Chang SL, Hegde JV, Loffredo MJ, D'Amico AV. PMID: 24787967.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. The effect of differing Gleason scores at biopsy on the odds of upgrading and the risk of death from prostate cancer. Clin Genitourin Cancer. 2014 Oct; 12(5):e181-7. Phillips JG, Aizer AA, Chen MH, Zhang D, Hirsch MS, Richie JP, Tempany CM, Williams S, Hegde JV, Loffredo MJ, D'Amico AV. PMID: 24721618; PMCID: PMC4153802.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging. 2013 May; 37(5):1035-54. Hegde JV, Mulkern RV, Panych LP, Fennessy FM, Fedorov A, Maier SE, Tempany CM. PMID: 23606141; PMCID: PMC3741996.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    46. Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):e101-7. Hegde JV, Chen MH, Mulkern RV, Fennessy FM, D'Amico AV, Tempany CM. PMID: 23040223; PMCID: PMC3545042.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    John's Networks
    Concepts (190)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (53)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California